LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
6.89
+0.06 (0.88%)
At close: Aug 13, 2025, 4:00 PM
6.71
-0.18 (-2.61%)
Pre-market: Aug 14, 2025, 9:07 AM EDT
LifeMD Market Cap
LifeMD has a market cap or net worth of $326.71 million as of August 14, 2025. Its market cap has increased by 9.89% in one year.
Market Cap
326.71M
Enterprise Value
312.53M
1-Year Change
9.89%
Ranking
Category
Stock Price
$6.89
Market Cap Chart
Since April 1, 2013, LifeMD's market cap has increased from $3.50M to $326.71M, an increase of 9,234.45%. That is a compound annual growth rate of 44.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 323.90M | 51.07% |
| Dec 31, 2024 | 214.40M | -31.89% |
| Dec 29, 2023 | 314.80M | 416.07% |
| Dec 30, 2022 | 61.00M | -48.48% |
| Dec 31, 2021 | 118.40M | -22.11% |
| Dec 31, 2020 | 152.00M | 2,391.80% |
| Dec 31, 2019 | 6.10M | -4.69% |
| Dec 31, 2018 | 6.40M | -57.62% |
| Dec 29, 2017 | 15.10M | 65.93% |
| Dec 30, 2016 | 9.10M | 145.95% |
| Dec 31, 2015 | 3.70M | 19.35% |
| Dec 31, 2014 | 3.10M | -59.21% |
| Dec 31, 2013 | 7.60M | 117.14% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |